跳至主要内容
临床试验/NCT05692687
NCT05692687已完成不适用

A Prospective, Non-comparative, Multi-centre, Post-market Clinical Study to Evaluate the Safety and Performance of the Carbon Fibre Reinforced Polyetheretherketone Metatarso-Phalangeal (MTP) Plate (CoLink® PCR MTP Plate) for the Treatment of Hallux Rigidus

Invibio Ltd6 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2023年3月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Invibio Ltd
入组人数
18
试验地点
6
主要终点
Bone Fusion

研究概览

简要总结

The clinical study involves the routine treatment of skeletally mature patients who have been diagnosed with hallux rigidus (stiffness of the first metatarso-phalangeal joint in the foot due to arthritis and degeneration of cartilage).

It follows standard practice surgery to treat this condition. This type of degenerative arthritis affects the joint of the big toe (hallux) which is attached to the foot. Taking part in this research will involve collecting data of the surgery to remove damaged cartilage and fix the two bones together with screws and a plate (called the CoLink® PCR MTP Plate).

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects aged 18 years of age or older (> 18 years) and are skeletally mature.
  • Subjects who require surgical treatment for hallux rigidus and have been evaluated as appropriate candidates for treatment with the CoLink® PCR MTP Plate by the Investigator.
  • Subjects who, in the opinion of the Investigator, are able to understand this clinical study, co-operate with the procedures and are willing to return to the hospital for all the required post-operative follow-ups.
  • Subjects who are able to give voluntary, written informed consent to participate in this clinical study and from whom consent has been obtained.

排除标准

  • Subjects who have previously undergone MTP fusion surgery or implant arthroplasty in the foot to be treated.
  • Subjects who require bi-lateral MTP fusion surgery.
  • Subjects with evidence of tumour and/or malignant disease with resultant life expectancy of less than two years.
  • Subjects with a known allergy to the material used in the instrumentation.
  • Subjects with evidence of an active infection and/or with any condition that would compromise their participation and follow-up in this clinical study.
  • Subjects who have any conditions outlined as contraindicated in the Instructions for Use.
  • Female subjects who are pregnant or lactating.
  • Subjects who are known drug or alcohol abusers, or with a baseline opioid use greater than 30 mg of morphine equivalent/day, or with psychological disorders that could affect follow-up care or treatment outcomes.
  • Subjects who are current smokers or have stopped smoking less than 6 months ago.
  • Subjects who are currently enrolled in a clinical study.

结局指标

主要结局

Bone Fusion

时间窗: 6 months

Successful radiographic union: where union is defined as 'evidence of bridging' between the metatarsal bone and proximal phalanx bone by an independent imaging company.

次要结局

未报告次要终点

研究者

发起方
Invibio Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验